Merck, NewLink Ebola vaccine appears safe, effective in new studies
April 01, 2015 at 17:00 PM EDT
NEW YORK, April 1 (Reuters) - Early-stage trials of an experimental Ebola vaccine, two in the United States and four in Africa and Europe, have found that it appears to be safe and triggered robust production of Ebola-fighting antibodies, scientists reported on Wednesday.